Main Article Content
Reduction in outpatient visits and laboratory testing during the Coronavirus Disease 2019 (COVID-19) pandemic has raised concerns about gaps in diabetes management and glycemic control.
We aimed to investigate the changes in the treatment and control of people with diabetes during the COVID-19 pandemic quarantine.
106 glycemic control patients from three districts of six general hospitals in Ulaanbaatar were randomly selected as applicants, and permission and questionnaires were obtained through telephone contact. The questionnaire was developed based on the "Diabetes Guidelines" issued by the Ministry of Health of Mongolia. These findings include average blood glucose (BG) of fasting BG, 2-h postprandial BG, and bedtime to assess diabetes control. The main evaluation indicators included drug supply, shortage, and adherence to self-management behaviors.
In total, 72.7% of participants were Type 2 Diabetes Mellitus (T2DM) and 83.3% of them were poorly controlled. 81.5% of the Type 1 Diabetes Mellitus (T1DM) participants had inadequate glycemic control. We retrospectively estimated the glycemic control using their previous HbA1c results. It shows that 70% and 72% of them were adversely controlled before the isolation although 79.7% of the respondents contacted their healthcare providers during the isolation period. All participants stopped treatment for an average of 50 ± 62.7 (p<0.05) days during the isolation period, 59% of which were due to drug supply and shortages, 41% due to isolation, and had to postpone. The average BG level before isolation was 8.4±6.9 mmol/l, the highest was 19.6±10.2 mmol/l, and during the isolation, the period was 8.9±5.3 mmol/l, the highest was 19.6±10.8 mmol/l. The maximum value is 50 mmol/l.
We need to develop telemedicine in Mongolia as a healthcare service. We conclude that glycemic control among patients with diabetes mellitus during quarantine is substandard.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
© Journal of Asian Medical Students’ Association (JAMSA). Released under a Creative Commons license.
Tao J, Gao L, Liu Q, et al. Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic. Diabetes Res Clin Pract. 2020;170:108514. doi:10.1016/j.diabres.2020.108514
Biamonte, E., Pegoraro, F., Carrone, F. et al. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine 72, 604–610 (2021).
Önmez, Attila, et al. "The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey." Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14.6 (2020): 1963-1966.
Ministry of Health Mongolia.“Diabetes Mellitus Clinical Guideline”. Ulaanbaatar, Mongolia, 2021. Available online: https://extranet.who.int/ncdccs/Data/MNG_D1_DM_Clinical_guidelines.pdf
Patel SY, McCoy RG, Barnett ML, Shah ND, Mehrotra A. Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States. JAMA Intern Med. 2021;181(10):1412–1414. doi:10.1001/jamainternmed.2021.3047
Eberle, C., Stichling, S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr 13, 95 (2021). https://doi.org/10.1186/s13098-021-00705-9